• Home
  • About

Posts | Comments | Email

My Blog

Medscape's 'Top 10' articles in 2007

Medscape has released its top 10 most read articles in 2007. Have a look. Some of which have been blogged (about) here before.

1. Pergolide Withdrawn From US Market

(in Pharm House: Parkinson's drug pulled out in US over concerns of Cardiac valvulopathy)

2. Imaging X-rays Cause Cancer: A Call to Action for Caregivers and Patients

3. Applying New NIH Guidelines for Pediatric Asthma: An Infant Who Has Failed Previous Asthma Therapy

4. The Rosiglitazone Aftermath: Legitimate Concerns or Hype?

5. New Limits to Ketek Use, FDA Says

6. Guidelines Updated for Adult Immunization Schedule

7. Marketing of Zelnorm Suspended; Drug Linked to Slight Increase in CV Events

(in Pharm House: Novartis discontinues Zelnorm over safety concerns)

8. AAP Recommends Autism Screening for All Infants

9. Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: AHRQ Executive Summary

10. Raising High-Density Lipoprotein Cholesterol: What Are We Learning From the Torcetrapib Experience?

(in Pharm House: 'ILLUMINATE' trial fails to illuminate Pfizer's hopes)






0 comments:

Post a Comment
Newer Post Older Post Home

 

About the Blogger

Seeji is a pharmaceutical physician from India. He writes about snippets of Pharma, the ‘Big’(!) pharma, Indian Pharma, clinical research, the science fraud, bioethics, biostats and some absolutely unrelated crap. An inborn error in cognitive function, made him too optimistic about industry and some may feel his views are biased. Please write in if you differ.
[Disclaimer: All views expressed in this blog are Seeji's and do not necessarily represent the views of his employer]

Design by ChiQ Montes. Converted to Blogger by Blogger Tricks